The promotion and reimbursement practices for the medtech company’s implantable CPAP alternative are under scrutiny.

CEO Tim Herbert told investors the company received a civil investigative demand from the Department of Justice in January ...

Inspire Medical shares dipped — but have since mostly recovered — following news of a government investigation following Q4 ...

Inspire Medical Systems, Inc. INSP delivered an earnings per share (EPS) of $1.15 in fourth-quarter 2024, up 134.7% from the ...

In a highly anticipated conference call, Inspire Medical Systems reported an impressive fourth quarter and full year 2024 ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Inspire Medical Systems (INSP – Research ...

Q4 2024 Earnings Call Transcript February 10, 2025 Inspire Medical Systems, Inc. beats earnings expectations. Reported EPS is ...

In a report released today, Richard Newitter from Truist Financial maintained a Buy rating on Inspire Medical Systems (INSP – Research Report).